Oaktree Acquisition III Life Sciences

OACC · NASDAQ

$10.71+$0.02 (+0.19%)TodayMarket closed · Oct 23, 4:00 PM ET

Prev close $10.69

About OACC

Oaktree Acquisition Corp. III Life Sciences is a blank check company, which was created for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company is headquartered in Los Angeles, California. The company went IPO on 2024-12-16. The firm is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. The firm has not commenced any operations. The firm has not generated any revenues.

Employees: 0
Headquarters: Los Angeles, California
Listed: Dec 16, 2024
Sector: N/A
Industry: N/A

Leadership

Oaktree Acquisition III Life Sciences executives
Name	Title	Age
John Frank	—	68
Zaid Pardesi	—	41
Alexander Taubman	—	36
Mathew Pendo	—	61
Mary-Catherine Lader	—	38
Patrick Mccaney	—	43
Alexandre Macedo	—	46
Marran Ogilvie	—	56

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.